The focus of Novo’s partnerships
Partnerships and licensing deals are necessary for Novo Nordisk if the company wants to develop the best possible drugs as fast as possible, says the man who ensures that the many partnerships and licensing agreements run smoothly. Read on to see what the Danish pharmaceutical company is focusing on at the moment.
by Stefan Singh Kailay
“The reason I created the alliance management function about four or five years ago was a recognition that our company primarily developed organically, inventing most of our products in-house. It means we are very much geared for organic growth, which offers many benefits. But it also means that we do not have so much experience in collaborating with others. So I am very pleased that we are now being recognized for focusing on it.”
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Novo Nordisk is the second-best partner
For abonnenter
